Lysophosphatidylethanolamine utilizes LPA1 and CD97 in MDA-MB-231 breast cancer cells

Cellular Signalling

Volumn 25, Issue 11, 2013, Pages 2147-2154

  Park, Soo Jin ^a   Lee, Kyoung Pil ^a   Kang, Saeromi ^a   Chung, Hae Young ^a   Bae, Yoe Sik ^b   Okajima, Fumikazu ^c   Im, Dong Soon ^a  

^a Pusan National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Breast; GPCR; LPA1; Lysophosphatidic acid; Lysophosphatidylethanolamine; Receptor

Indexed keywords

CALCIUM ION; CD97 ANTIGEN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID 1; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CONTROLLED STUDY; DESENSITIZATION; HUMAN; HUMAN CELL; LIPID ANALYSIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

(S)-PHOSPHORIC ACID MONO-{2-OCTADEC-9-ENOYLAMINO-3-[4-(PYRIDIN-2-YLMETHOXY)-PHENYL]-PROPYL} ESTER; 2-AMINOETHOXYDIPHENYLBORANE; 2-APB; 3-(4-[4-([1-(2-CHLOROPHENYL)ETHOXY]CARBONYLAMINO)-3-METHYL-5-ISOXAZOLYL]BENZYLTHIO) PROPANOIC ACID; BREAST; G-PROTEIN-COUPLED RECEPTOR; GPCR; INOSITOL 1,4,5-TRISPHOSPHATE; IP(3); KI16425; LPA; LPA(1); LPA(2); LPA(3); LPA(4); LPA(5); LPA(6); LPE; LPG; LPS; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR 3 (EDG7); LYSOPHOSPHATIDIC ACID RECEPTOR 5 (GPR92); LYSOPHOSPHATIDIC ACID RECEPTOR 6 (P2Y5); LYSOPHOSPHATIDIC ACID RECEPTOR TYPE 1 (EDG2); LYSOPHOSPHATIDIC ACID RECEPTOR TYPE 2 (EDG4); LYSOPHOSPHATIDIC ACID RECEPTOR TYPE 4 (GPR23); LYSOPHOSPHATIDYLETHANOLAMINE; LYSOPHOSPHATIDYLGLYCEROL; LYSOPHOSPHATIDYLSERINE; PERTUSSIS TOXIN; PTX; RECEPTOR; VPC32183;

ANTIGENS, CD; BORON COMPOUNDS; CALCIUM; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; ISOXAZOLES; LYSOPHOSPHOLIPIDS; ORGAN SPECIFICITY; ORGANOPHOSPHATES; PERTUSSIS TOXIN; PROPIONATES; PYRIDINES; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES;

EID: 84881096255     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.07.001     Document Type: Article

References (38)

1. Choi J.W., Chun J. Biochimica et Biophysica Acta 2013, 1831:20-32.
2. Park K.S., Lee H.Y., Kim M.K., Shin E.H., Bae Y.S. Biochemical and Biophysical Research Communications 2005, 333:353-358.
3. Park K.S., Lee H.Y., Kim M.K., Shin E.H., Jo S.H., Kim S.D., Im D.S., Bae Y.S. Molecular Pharmacology 2006, 69:1066-1073.
4. Park K.S., Lee H.Y., Lee S.Y., Kim M.K., Kim S.D., Kim J.M., Yun J., Im D.S., Bae Y.S. FEBS Letters 2007, 581:4411-4416.
5. Jo S.H., Kim S.D., Kim J.M., Lee H.Y., Lee S.Y., Shim J.W., Yun J., Im D.S., Bae Y.S. Biochemical and Biophysical Research Communications 2008, 372:147-151.
6. Lee S.Y., Lee H.Y., Kim S.D., Jo S.H., Shim J.W., Lee H.J., Yun J., Bae Y.S. Biochemical and Biophysical Research Communications 2008, 374:147-151.
7. Makide K., Kitamura H., Sato Y., Okutani M., Aoki J. Prostaglandins & Other Lipid Mediators 2009, 89:135-139.
8. Sugo T., Tachimoto H., Chikatsu T., Murakami Y., Kikukawa Y., Sato S., Kikuchi K., Nagi T., Harada M., Ogi K., Ebisawa M., Mori M. Biochemical and Biophysical Research Communications 2006, 341:1078-1087.
9. Kitamura H., Makide K., Shuto A., Ikubo M., Inoue A., Suzuki K., Sato Y., Nakamura S., Otani Y., Ohwada T., Aoki J. Journal of Biochemistry 2012, 151:511-518.
10. Iwashita M., Makide K., Nonomura T., Misumi Y., Otani Y., Ishida M., Taguchi R., Tsujimoto M., Aoki J., Arai H., Ohwada T. Journal of Medicinal Chemistry 2009, 52:5837-5863.
11. Ritscher L., Engemaier E., Staubert C., Liebscher I., Schmidt P., Hermsdorf T., Rompler H., Schulz A., Schoneberg T. Biochemical Journal 2012, 443:841-850.
12. Liebscher I., Muller U., Teupser D., Engemaier E., Engel K.M., Ritscher L., Thor D., Sangkuhl K., Ricken A., Wurm A., Piehler D., Schmutzler S., Fuhrmann H., Albert F.W., Reichenbach A., Thiery J., Schoneberg T., Schulz A. Journal of Biological Chemistry 2011, 286:2101-2110.
13. Misra U.K. Biochimica et Biophysica Acta 1965, 106:371-378.
14. Jo J.Y., Kim H.L., Lee Y.K., Tomura H., Bae Y.S., Okajima F., Im D.S. Journal of Pharmacological Sciences 2008, 107:303-307.
15. Chang Y.J., Kim Y.L., Lee Y.K., Sacket S.J., Kim K., Kim H.L., Han M., Bae Y.S., Okajima F., Im D.S. Prostaglandins & Other Lipid Mediators 2007, 83:268-276.
16. Damirin A., Tomura H., Komachi M., Liu J.P., Mogi C., Tobo M., Wang J.Q., Kimura T., Kuwabara A., Yamazaki Y., Ohta H., Im D.S., Sato K., Okajima F. American Journal of Physiology. Heart and Circulatory Physiology 2007, 292:H2513-H2522.
17. Melchior B., Frangos J.A. American Journal of Physiology. Cell Physiology 2012, 303:C467-C473.
18. Chang Y.J., Kim H.L., Sacket S.J., Kim K., Han M., Jo J.Y., Im D.S. Journal of Applied Pharmacology 2007, 15:150-155.
19. Zhang Y., Chen Y.C., Krummel M.F., Rosen S.D. Journal of Immunology 2012, 189:3914-3924.
20. Ohta H., Sato K., Murata N., Damirin A., Malchinkhuu E., Kon J., Kimura T., Tobo M., Yamazaki Y., Watanabe T., Yagi M., Sato M., Suzuki R., Murooka H., Sakai T., Nishitoba T., Im D.S., Nochi H., Tamoto K., Tomura H., Okajima F. Molecular Pharmacology 2003, 64:994-1005.
21. Heise C.E., Santos W.L., Schreihofer A.M., Heasley B.H., Mukhin Y.V., Macdonald T.L., Lynch K.R. Molecular Pharmacology 2001, 60:1173-1180.
22. Noguchi K., Ishii S., Shimizu T. Journal of Biological Chemistry 2003, 278:25600-25606.
23. Yanagida K., Ishii S., Hamano F., Noguchi K., Shimizu T. Journal of Biological Chemistry 2007, 282:5814-5824.
24. Lee C.W., Rivera R., Gardell S., Dubin A.E., Chun J. Journal of Biological Chemistry 2006, 281:23589-23597.
25. Lee C.W., Rivera R., Dubin A.E., Chun J. Journal of Biological Chemistry 2007, 282:4310-4317.
26. Kotarsky K., Boketoft A., Bristulf J., Nilsson N.E., Norberg A., Hansson S., Sillard R., Owman C., Leeb-Lundberg F.L., Olde B. Journal of Pharmacology and Experimental Therapeutics 2006, 318:619-628.
27. Ward Y., Lake R., Yin J.J., Heger C.D., Raffeld M., Goldsmith P.K., Merino M., Kelly K. Cancer Research 2011, 71:7301-7311.
28. Ward Y., Lake R., Martin P.L., Killian K., Salerno P., Wang T., Meltzer P., Merino M., Cheng S.Y., Santoro M., Garcia-Rostan G., Kelly K. Oncogene 2013, 32:2726-2738.
29. Yoshioka K., Saitoh O., Nakata H. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:7617-7622.
30. Swaney J.S., Chapman C., Correa L.D., Stebbins K.J., Bundey R.A., Prodanovich P.C., Fagan P., Baccei C.S., Santini A.M., Hutchinson J.H., Seiders T.J., Parr T.A., Prasit P., Evans J.F., Lorrain D.S. British Journal of Pharmacology 2010, 160:1699-1713.
31. Swaney J.S., Chapman C., Correa L.D., Stebbins K.J., Broadhead A.R., Bain G., Santini A.M., Darlington J., King C.D., Baccei C.S., Lee C., Parr T.A., Roppe J.R., Seiders T.J., Ziff J., Prasit P., Hutchinson J.H., Evans J.F., Lorrain D.S. Journal of Pharmacology and Experimental Therapeutics 2011, 336:693-700.
32. Castelino F.V., Seiders J., Bain G., Brooks S.F., King C.D., Swaney J.S., Lorrain D.S., Chun J., Luster A.D., Tager A.M. Arthritis and Rheumatism 2011, 63:1405-1415.
33. Morishita K., Aiboshi J., Kobayashi T., Mikami S., Yokoyama Y., Ogawa K., Yokota H., Otomo Y. Journal of Trauma and Acute Care Surgery 2012, 72:1541-1547.
34. Nishina A., Kimura H., Sekiguchi A., Fukumoto R.H., Nakajima S., Furukawa S. Journal of Lipid Research 2006, 47:1434-1443.
35. Hung N.D., Kim M.R., Sok D.E. Lipids 2011, 46:893-906.
36. Im D.S. Archives of Pharmacal Research 2012, 35:945-948.
37. Im D.S. Trends in Pharmacological Sciences 2003, 24:2-4.
38. Cyster J.G., Schwab S.R. Annual Review of Immunology 2012, 30:69-94.